INSULET CORPORATION (PODD) Current Ratio
- Current ratio · latest quarter: Value 2.48×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 2.48× | Current assets / current liabilities. $1.85B ÷ $744.20M ≈ 2.48× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.85B USD | Assets, Current |
| Current obligations | 744.20M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 588.70M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 484.80M USD | Inventory, Net |
| Payables | 123.30M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 18.90M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.85B | $744.20M | (m) | (m) | $588.70M | $484.80M | $123.30M | $18.90M | 2.48× |
| 2026-03-31 | $1.71B | $687.50M | (m) | (m) | $544.70M | $462.50M | $149.80M | $18.60M | 2.49× |
| 2025-12-31 | $1.91B | $680.10M | (m) | (m) | $516.90M | $452.60M | $75.00M | $18.40M | 2.81× |
| 2025-09-30 | $1.86B | $647.70M | (m) | (m) | (m) | $446.30M | $48.20M | $79.90M | 2.87× |
| 2025-06-30 | $2.28B | $1.01B | (m) | (m) | (m) | $446.90M | $96.10M | $460.70M | 2.26× |
| 2025-03-31 | $2.33B | $520.40M | (m) | (m) | (m) | $440.80M | $57.60M | $83.10M | 4.47× |
| 2024-12-31 | $1.89B | $528.40M | (m) | (m) | (m) | $430.40M | $19.80M | $83.80M | 3.58× |
| 2024-09-30 | $1.86B | $506.20M | (m) | (m) | (m) | $444.90M | $40.30M | $42.00M | 3.68× |
| 2024-06-30 | $1.75B | $486.00M | (m) | (m) | (m) | $430.90M | $76.80M | $37.90M | 3.60× |
| 2024-03-31 | $1.62B | $432.40M | (m) | (m) | (m) | $430.60M | $75.90M | $38.90M | 3.74× |
| 2023-12-31 | $1.58B | $451.20M | (m) | (m) | (m) | $402.60M | $19.20M | $49.40M | 3.51× |
| 2023-09-30 | $1.47B | $451.40M | (m) | (m) | (m) | $410.80M | $77.80M | $49.80M | 3.26× |
| 2023-06-30 | $1.42B | $425.00M | (m) | (m) | (m) | $411.30M | $107.50M | $29.20M | 3.34× |
| 2023-03-31 | $1.33B | $383.30M | (m) | (m) | $159.60M | $386.10M | $85.90M | $27.80M | 3.47× |
| 2022-12-31 | $1.31B | $364.70M | (m) | (m) | (m) | $346.80M | $30.80M | $27.50M | 3.60× |
| 2022-09-30 | $1.33B | $334.20M | (m) | (m) | $153.10M | $327.60M | $62.10M | $26.90M | 3.98× |
| 2022-06-30 | $1.31B | $279.30M | (m) | (m) | $154.10M | $320.40M | $57.20M | $26.30M | 4.69× |
| 2022-03-31 | $1.29B | $215.00M | (m) | (m) | $153.50M | $314.80M | $52.20M | $25.70M | 5.98× |
| 2021-12-31 | $1.33B | $228.80M | (m) | (m) | $135.20M | $303.20M | $37.70M | $25.10M | 5.81× |
| 2021-09-30 | $1.31B | $228.60M | $856.60M | $500.00K | $114.30M | $259.00M | $58.00M | $28.90M | 5.72× |
| 2021-06-30 | $1.25B | $213.30M | $854.60M | $17.50M | $100.30M | $197.80M | $49.30M | $20.90M | 5.87× |
| 2021-03-31 | $1.19B | $185.50M | $820.70M | $29.50M | $97.90M | $170.10M | $59.10M | $15.70M | 6.42× |
| 2020-12-31 | $1.25B | $207.80M | (m) | $40.40M | $95.30M | $154.30M | $54.10M | $15.60M | 6.01× |
| 2020-09-30 | $1.16B | $175.20M | $838.10M | $58.60M | $85.40M | $124.90M | $57.00M | (m) | 6.62× |
| 2020-06-30 | $1.09B | $134.40M | $779.10M | $65.30M | $78.00M | $103.70M | $35.60M | (m) | 8.08× |
| 2020-03-31 | $541.30M | $130.40M | $201.40M | $120.20M | $80.10M | $95.70M | $36.40M | (m) | 4.15× |
| 2019-12-31 | $591.00M | $157.70M | $213.70M | $162.40M | $69.30M | $101.00M | $54.50M | $0.00 | 3.75× |
| 2019-09-30 | $793.90M | $113.28M | $419.88M | $185.62M | $65.05M | $90.21M | $21.25M | (m) | 7.01× |
| 2019-06-30 | $498.81M | $105.77M | $119.87M | $189.88M | $66.96M | $85.11M | $24.75M | (m) | 4.72× |
| 2019-03-31 | $496.38M | $113.97M | $129.25M | $187.12M | $68.66M | $73.82M | $26.83M | (m) | 4.36× |
| 2018-12-31 | $461.30M | $115.70M | $113.90M | $175.00M | $63.30M | $71.40M | $25.50M | (m) | 3.99× |
| 2018-09-30 | $445.71M | $97.22M | $126.56M | $163.28M | $69.95M | $58.05M | $26.84M | (m) | 4.58× |
| 2018-06-30 | $421.79M | $76.11M | $136.25M | $163.55M | $49.68M | $40.81M | $25.19M | (m) | 5.54× |
| 2018-03-31 | $451.61M | $82.41M | $203.15M | $148.85M | $50.38M | $26.33M | $33.85M | $3.45M | 5.48× |
| 2018-01-01 | $547.11M | $88.65M | (m) | (m) | (m) | $33.04M | (m) | (m) | 6.17× |
| 2017-12-31 | $537.17M | $86.03M | $272.58M | $167.48M | $53.37M | $33.79M | $24.41M | (m) | 6.24× |
| 2017-09-30 | $366.02M | $74.94M | $102.23M | $173.52M | $47.17M | $35.05M | $28.65M | (m) | 4.88× |
| 2017-06-30 | $338.75M | $48.02M | $73.49M | $185.12M | $37.75M | $33.96M | $12.24M | (m) | 7.05× |
| 2017-03-31 | $337.17M | $39.38M | $76.04M | $177.99M | $40.65M | $34.33M | $6.41M | (m) | 8.56× |
| 2016-12-31 | $369.96M | $55.70M | $137.17M | $161.40M | $28.80M | $35.51M | $13.16M | (m) | 6.64× |
| 2016-09-30 | $361.81M | $54.25M | $215.40M | $67.29M | $38.55M | $32.66M | $18.21M | (m) | 6.67× |
| 2016-06-30 | $181.29M | $55.18M | $75.66M | $35.60M | $38.70M | $24.49M | $21.61M | (m) | 3.29× |
| 2016-03-31 | $171.84M | $49.77M | $111.64M | (m) | $40.47M | $14.02M | $13.48M | (m) | 3.45× |
| 2015-12-31 | $190.76M | $65.16M | $122.67M | $0.00 | $42.53M | $12.02M | $15.21M | (m) | 2.93× |
| 2015-09-30 | $194.34M | $59.44M | $145.47M | (m) | $31.80M | $13.02M | $15.61M | (m) | 3.27× |
| 2015-06-30 | $203.83M | $52.68M | $145.14M | (m) | $31.83M | $23.43M | $17.92M | (m) | 3.87× |
| 2015-03-31 | $205.43M | $47.38M | $145.61M | (m) | $36.09M | $20.07M | $14.25M | (m) | 4.34× |
| 2014-12-31 | $208.20M | $44.30M | $151.19M | (m) | $35.24M | $11.45M | $12.58M | (m) | 4.70× |
| 2014-09-30 | $206.61M | $47.76M | $146.37M | (m) | $47.15M | $9.66M | $17.73M | (m) | 4.33× |
| 2014-06-30 | $231.83M | $71.20M | $175.54M | (m) | $41.80M | $8.77M | $18.61M | $23.87M | 3.26× |
| 2014-03-31 | $199.86M | $43.12M | $145.61M | (m) | $36.68M | $10.45M | $20.98M | (m) | 4.64× |
| 2013-12-31 | $198.20M | $42.37M | $149.73M | (m) | $33.07M | $9.46M | $19.36M | (m) | 4.68× |
| 2013-09-30 | $199.69M | $48.29M | $153.91M | (m) | $34.47M | $5.39M | $15.12M | $0.00 | 4.13× |
| 2013-06-30 | $197.13M | $33.85M | $150.94M | (m) | $33.65M | $5.98M | $11.44M | $0.00 | 5.82× |
| 2013-03-31 | $194.76M | $42.98M | $148.06M | (m) | $31.11M | $9.20M | $8.54M | $14.73M | 4.53× |
| 2012-12-31 | $109.94M | $48.29M | $57.29M | (m) | $33.29M | $14.87M | $9.36M | $14.43M | 2.28× |
| 2012-09-30 | $114.24M | $49.34M | $63.44M | (m) | $30.14M | $15.09M | $16.22M | $14.13M | 2.32× |
| 2012-06-30 | $116.47M | $43.14M | $70.14M | (m) | $25.59M | $16.43M | $13.69M | $13.85M | 2.70× |
| 2012-03-31 | $128.22M | $32.58M | $83.01M | (m) | $26.20M | $14.70M | $16.11M | (m) | 3.94× |
| 2011-12-31 | $132.63M | $28.00M | $93.95M | (m) | $23.19M | $11.84M | $11.42M | (m) | 4.74× |
| 2010-12-31 | $142.46M | $18.95M | $113.27M | (m) | $16.84M | $11.43M | $4.89M | (m) | 7.52× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |